Quoin Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights

Quoin Pharmaceuticals Ltd share price today is $8.21, up -3.86%. The stock opened at $8 against the previous close of $8.26, with an intraday high of $8.07 and low of $8.

Quoin Pharmaceuticals Ltd Share Price Chart

Quoin Pharmaceuticals Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Quoin Pharmaceuticals Ltd Share Price Performance

$8.21 -0.0386(-3.86%) QNRX at 23 Mar 2026 02:56 PM Biotechnology
Lowest Today 8
Highest Today 8.07
Today’s Open 8
Prev. Close 8.26
52 Week High 23.50
52 Week Low 5.01
Day’s Range: Low 8 High 8.07
52-Week Range: Low 5.01 High 23.50
1 day return -
1 Week return +2.04
1 month return -1.71
3 month return -42.81
6 month return +13.96
1 year return +2611.86
3 year return +26.28
5 year return -99.63
10 year return -

Quoin Pharmaceuticals Ltd Institutional Holdings

Woodline Partners LP 4.92

Stonepine Capital Management Llc 4.84

Aberdeen Group PLC 4.64

Millennium Management LLC 4.63

SummitTX Capital, L.P 4.01

BOOTHBAY FUND MANAGEMENT, LLC 3.70

ADAR1 Capital Management LLC 3.60

AIGH Capital Management, LLC 3.05

abrdn World Healthcare 2.50

abrdn Life Sciences Investors 2.14

Resolute Capital Asset Partners LLC 1.86

Simplify Asset Management Inc. 1.08

Centiva Capital LP 0.75

Abante Quant Value FI 0.18

GAMMA Investing LLC 0.13

Rhumbline Advisers 0.10

SBI Securities Co Ltd 0.02

UBS Group AG 0.00

Morgan Stanley - Brokerage Accounts 0.00

Quoin Pharmaceuticals Ltd Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Quoin Pharmaceuticals Ltd Fundamentals

Market Cap 12.83 M

PB Ratio 2.7194

PE Ratio 0.0

Enterprise Value 7.42 M

Total Assets 15.71 M

Volume 12268

Quoin Pharmaceuticals Ltd Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-8637655 -8.6M, FY22:-9277453 -9.3M, FY21:-8518668 -8.5M, FY20:-1764052 -1.8M, FY19:-1560401 -1.6M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-25520 -0.0M, Q1/2025:-24870 -0.0M, Q3/2024:null 0.0M, Q2/2024:-24908 -0.0M

Quarterly Net worth Q3/2025:-3948165 -3.9M, Q2/2025:-3695938 -3.7M, Q1/2025:-3812179 -3.8M, Q3/2024:-2349885 -2.3M, Q2/2024:-1966836 -2.0M

About Quoin Pharmaceuticals Ltd & investment objective

Company Information Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.

Organisation Biotechnology

Employees 3

Industry Biotechnology

CEO Dr. Michael Myers Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Quoin Pharmaceuticals Ltd FAQs

What is the share price of Quoin Pharmaceuticals Ltd today?

The current share price of Quoin Pharmaceuticals Ltd is $8.21.

Can I buy Quoin Pharmaceuticals Ltd shares in India?

Yes, Indian investors can buy Quoin Pharmaceuticals Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Quoin Pharmaceuticals Ltd shares in India?

You can easily invest in Quoin Pharmaceuticals Ltd shares from India by:

Can I buy fractional shares of Quoin Pharmaceuticals Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Quoin Pharmaceuticals Ltd?

Quoin Pharmaceuticals Ltd has a market cap of $12.83 M.

In which sector does Quoin Pharmaceuticals Ltd belong?

Quoin Pharmaceuticals Ltd operates in the Biotechnology sector.

What documents are required to invest in Quoin Pharmaceuticals Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Quoin Pharmaceuticals Ltd?

The PE ratio of Quoin Pharmaceuticals Ltd is N/A and the PB ratio is 2.72.